| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Clinigence Holdings, Inc. | Director | Director Stock Option (right to buy) | 85,120 | $234,080 | $2.75 | 05 Aug 2020 | Direct |
| Clinigence Holdings, Inc. | Director | Common Stock | 277,259 | $62,661 | $0.2260 | 28 Jan 2021 | Direct |
| Apollo Medical Holdings, Inc. | Director | Stock Option (right to buy) | 8,500 | 20 Jan 2022 | Direct | ||
| Clinigence Holdings, Inc. | Director | Warrants to Puchase common stock | 3,598 | 21 Mar 2019 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000182912625004566-fawcett-mark-2025-06-17 | Pioneer Acquisition I Corp | 17 Jun 2025 | 0 | $0 | 3 | Director | 17 Jun 2025, 17:41 |
| ASTH | Apollo Medical Holdings, Inc. | 20 Jan 2022 | 1 | $0 | 4 | Director | 24 Jan 2022, 15:18 |
| NUTX | Clinigence Holdings, Inc. | 25 Feb 2021 | 3 | +$571,255 | 4 | Director | 21 Dec 2021, 12:26 |